Equities

Elanco Animal Health Inc

Elanco Animal Health Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)15.07
  • Today's Change0.42 / 2.87%
  • Shares traded17.39m
  • 1 Year change+27.17%
  • Beta1.4082
Data delayed at least 15 minutes, as of Sep 20 2024 00:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments352345638
Total Receivables, Net1,0101,0021,028
Total Inventory1,7351,5381,373
Prepaid expenses310394237
Other current assets, total----0
Total current assets3,4073,2793,276
Property, plant & equipment, net1,1661,1401,222
Goodwill, net5,0945,9936,172
Intangibles, net4,4944,8425,587
Long term investments262722
Note receivable - long term------
Other long term assets175210204
Total assets14,36215,49116,483
LIABILITIES
Accounts payable270390418
Accrued expenses189177219
Notes payable/short-term debt000
Current portion long-term debt/capital leases38388294
Other current liabilities, total744747712
Total current liabilities1,2411,7021,643
Total long term debt5,7365,4486,025
Total debt5,7745,8366,319
Deferred income tax567662745
Minority interest------
Other liabilities, total595390532
Total liabilities8,1398,2028,945
SHAREHOLDERS EQUITY
Common stock000
Additional paid-in capital8,7778,7388,696
Retained earnings (accumulated deficit)(2288)(1057)(949)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(266)(392)(209)
Total equity6,2237,2897,538
Total liabilities & shareholders' equity14,36215,49116,483
Total common shares outstanding493474473
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.